Bocchetta M - Search Results

1

Advances in prophylactic cancer vaccine research.

Le Poole IC, Bommiasamy H, Bocchetta M, Kast WM. Le Poole IC, et al. Among authors: bocchetta m. Expert Rev Anticancer Ther. 2003 Aug;3(4):537-45. doi: 10.1586/14737140.3.4.537. Expert Rev Anticancer Ther. 2003. PMID: 12934665 Review.

2

Notch signaling in lung cancer.

Galluzzo P, Bocchetta M. Galluzzo P, et al. Among authors: bocchetta m. Expert Rev Anticancer Ther. 2011 Apr;11(4):533-40. doi: 10.1586/era.10.158. Expert Rev Anticancer Ther. 2011. PMID: 21504320 Free PMC article. Review.

3

New developments about the association of SV40 with human mesothelioma.

Carbone M, Pass HI, Miele L, Bocchetta M. Carbone M, et al. Among authors: bocchetta m. Oncogene. 2003 Aug 11;22(33):5173-80. doi: 10.1038/sj.onc.1206552. Oncogene. 2003. PMID: 12910254 Review.

4

Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications.

Carbone M, Rizzo P, Powers A, Bocchetta M, Fresco R, Krausz T. Carbone M, et al. Among authors: bocchetta m. Anticancer Res. 2002 Nov-Dec;22(6B):3443-8. Anticancer Res. 2002. PMID: 12552937

5

Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.

Cutrone R, Lednicky J, Dunn G, Rizzo P, Bocchetta M, Chumakov K, Minor P, Carbone M. Cutrone R, et al. Among authors: bocchetta m. Cancer Res. 2005 Nov 15;65(22):10273-9. doi: 10.1158/0008-5472.CAN-05-2028. Cancer Res. 2005. PMID: 16288015

6

Polio vaccines, SV40 and human tumours, an update on false positive and false negative results.

Elmishad AG, Bocchetta M, Pass HI, Carbone M. Elmishad AG, et al. Among authors: bocchetta m. Dev Biol (Basel). 2006;123:109-17; discussion 119-32. Dev Biol (Basel). 2006. PMID: 16566440

7

High throughput testing of the SV40 Large T antigen binding to cellular p53 identifies putative drugs for the treatment of SV40-related cancers.

Carbone M, Rudzinski J, Bocchetta M. Carbone M, et al. Among authors: bocchetta m. Virology. 2003 Oct 25;315(2):409-14. doi: 10.1016/s0042-6822(03)00547-6. Virology. 2003. PMID: 14585344 Free article.

8

Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation.

Bocchetta M, Carbone M. Bocchetta M, et al. Oncogene. 2004 Aug 23;23(38):6484-91. doi: 10.1038/sj.onc.1207855. Oncogene. 2004. PMID: 15322519 Review.

9

SV40 and the pathogenesis of mesothelioma.

Rizzo P, Bocchetta M, Powers A, Foddis R, Stekala E, Pass HI, Carbone M. Rizzo P, et al. Among authors: bocchetta m. Semin Cancer Biol. 2001 Feb;11(1):63-71. doi: 10.1006/scbi.2000.0347. Semin Cancer Biol. 2001. PMID: 11243900 Review.

10

Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung.

Chen Y, De Marco MA, Graziani I, Gazdar AF, Strack PR, Miele L, Bocchetta M. Chen Y, et al. Among authors: bocchetta m. Cancer Res. 2007 Sep 1;67(17):7954-9. doi: 10.1158/0008-5472.CAN-07-1229. Cancer Res. 2007. PMID: 17804701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page